CF
TBPH icon

Corebridge Financial’s Theravance Biopharma TBPH Stock Holding History

Corebridge Financial’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,219
Closed -$163K – 2489
2025
Q1 		$163K Sell
18,219
-39
-0.2% -$363 ﹤0.01% 2188
2024
Q4 		$172K Sell
18,258
-1,378
-7% -$12.5K ﹤0.01% 2264
2024
Q3 		$158K Sell
19,636
-121
-0.6% -$1.05K ﹤0.01% 2354
2024
Q2 		$168K Buy
+19,757
New +$178K ﹤0.01% 2309

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Corebridge Financial's TBPH Position: Q2 2025 in Review

Corebridge Financial sold out of Theravance Biopharma (TBPH) in Q2 2025, closing a stake of 18,219 shares — an estimated $163K sold.

Corebridge Financial first reported a position in TBPH in Q2 2024 and held it in 4 quarters. The position peaked at $172K in Q4 2024. 135 funds tracked by Wall St. Rank hold TBPH as of Q2 2025.

  • Corebridge Financial reported no remaining Theravance Biopharma position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 18,219 Theravance Biopharma shares in Q2 2025, an estimated $163K.
  • Corebridge Financial first reported a position in Theravance Biopharma in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Theravance Biopharma position peaked at $172K in Q4 2024.
  • 135 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.